HepQuant®, LLC was formed as a limited liability company in Colorado in June 2007 by a small group of investors and the inventor, Dr. Gregory T. Everson. Dr. Everson is the Chief Scientific Officer of HepQuant, LLC, and is a leader in the field of Hepatology. Initial investors funded HepQuant with the acquisition of its first Liquid Chromatography Mass Spectrometry (LCMS) equipment. This equipment has been used to run the HepQuant test and fine-tune test methods. With the help of a Proof of Concept Award and two Bioscience Discovery Evaluation grants and matching funds, HepQuant has enlisted consultants in regulatory, legal and intellectual property matters and has made progress in both laboratory methods and clinical applications.